Don’t Miss ACT-AD’s Webinar on Personalized Medicine
ACT-AD will host a webinar this Monday, February 29, at 3:00 p.m. ET, on personalized medicine and Alzheimer’s disease. Speakers include:Jason H. Karlawish, M.D., J. Michael Ryan, M.D., Cara Tenenbaum, J.D., MBA, and Cynthia A. Bens. To register, please go here. Please note that we’ll be making the webinar available on demand. Information will be available in next month’s edition of The Alzheimer’s Advocate.
New Study Suggests Incidence of Dementia May Be Declining
A new study published in The New England Journal of Medicine reveals that the “age-specific” incidence of dementia may be declining in some high-income countries. The study focused on participants in the Framington Heart Study over three decades. At this time, experts cannot point to specific factors contributing to this finding. Read more here.
Experts ID Part of the Brain That May Be First Impacted by Alzheimer’s Disease Onset
Experts at the University of Southern California report that the locus coeruleus region of the brain may be the first area to be affected by late onset of AD. They say it could be the “Ground Zero” of the disease. The study finds that it is the first brain region to “show tau pathology—the slow-spreading tangles of protein that can later become telltale signs of Alzheimer’s disease.” Learn more here.
Bill to Create Alzheimer’s Stamp Introduced in House
A bill, H.R. 3092, has been submitted to the U.S. House of Representatives for issue of an Alzheimer’s Disease Research Semipostal Stamp. Proceeds for the sales of this stamp would go to the National Institutes of Health. To learn more about this effort, please go here.